We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Unveils Action Plan to Boost Biosimilars
FDA Commissioner Scott Gottlieb announced the release of a new action plan for biosimilars and said it would help prime the “anemic” biosimilar market.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor